跳到正文
研踪PaperTrail

论文库

检索计算机领域论文,按研究方向、作者或关键词筛选。

部分采集异常
正在读取账号与研究记录…

全站更新概况

+1680新增论文
+1333其中 AI 相关
+187已有论文修订
+59新增 AI 导读

arXiv 最近完成扫描:2026-11-18 04:28 · 全站最近入库:2026-11-17 23:35各信源进度 →

统计口径与数据新鲜度

统计 2026-11-17 09:49 — 2026-11-18 09:49(北京时间) · 点击数字查看对应简报;AI 相关包含在新增论文内。

最近完成检查:2026-11-18 04:28最近发现新增版本:2026-11-17 23:35库内论文最新更新时间:2026-11-17 02:59

每分钟刷新已保存的数据。空检查不代表采集异常;新收录可能包含历史论文。AI 导读按新增版本计数。

25,786 已收录论文21,491 AI 相关7,725 有修订112 HF 社区发现

浏览论文库

时间范围跟随排序:版本更新、本站收录或首次发表。最新收录可能包含历史论文。部分信源异常,查看状态 →

找到 2 篇论文 · 按版本更新时间排序上轮扫描起点 2026-11-18 04:27(北京时间)
新论文 · v1arXiv:2611.07653

PharmAgents2: Towards Autonomous End-to-End Drug Discovery

Haichuan Tan, Bowen Gao, Tao Huang, Jiaxin Tan, Xin Hong, Baoguo Yao, Yifei Wang, Zhichao Deng 等 25 位作者

原文摘要

Drug discovery requires continuous scientific decision-making across a vast research space. We introduce PharmAgents2, an autonomous system for end-to-end drug discovery that combines knowledge-enhanced decision-making with organized large-scale exploration. Paper2Skill extracts transferable scientific decision knowledge from public sources and, together with expert-developed skills, supports research decisions. Self-Scaling Discovery expands exploration through parallel agents inheriting research context and decision-making capabilities across targets, scientific hypotheses, and discovery strategies. We introduce PharmAgents-Bench v0.1, comprising 121 questions across nine decision scenarios and three end-to-end tasks assessed with expert-defined process rubrics. PharmAgents2 outperforms evaluated baselines in most decision categories and achieves the highest process scores on all three end-to-end tasks. In three real-world studies, autonomous investigations generated findings subsequently supported by human-executed experiments. For LpxH, PharmAgents2 hypothesized a previously unreported allosteric site and screened compounds against it, identifying a novel inhibitor scaffold with experimentally confirmed inhibitory activity and binding. For JAK1, it prioritized a covalent inhibition strategy and nominated compounds with experimentally demonstrated activity. Starting from a known bioactive molecule, Self-Scaling Discovery explored candidate targets across the proteome and identified a new binding target, with the interaction subsequently confirmed experimentally. PharmAgents2 represents a prototype of a virtual pharmaceutical company, marking a step toward autonomous end-to-end drug discovery.

cs.AI · q-bio.QM

首次观测 · 记录 #1ACL Anthology · ACL 2026:acl:2026.acl-long.406ACL Anthology · ACL 2026

Visual Attention Reasoning via Hierarchical Search and Self-Verification

Wei Cai, Jian Zhao, Yuchen Yuan China Telecom, Tianle Zhang China Telecom, Ming Zhu China Railway Rolling Stock Corporation Limited, Haichuan Tang CRRC ACADEMY, Xuelong Li China Telecom and Northwestern Polytechnical University

原文摘要

Multimodal Large Language Models (MLLMs) frequently hallucinate due to their reliance on fragile, linear reasoning and weak visual grounding. We propose Visual Attention Reasoning (VAR), a reinforcement learning framework that reformulates reasoning as a hierarchical search with self-verification. VAR enforces traceable evidence grounding by generating explicit bounding boxes, guided by a novel reward function combining geometric precision and semantic sufficiency. Furthermore, it replaces linear Chain-of-Thought with a tree-search policy capable of backtracking to correct logical errors. Theoretical analysis validates the framework’s reliability, and extensive experiments demonstrate that VAR significantly outperforms state-of-the-art methods on complex hallucination and safety benchmarks.

cs.CL · cs.CV

Proceedings of the 64th Annual Meeting of the Association for Computational Linguistics (Volume 1: Long Papers) · 2026 · 正式发表